Author: Andrew Rogers

For generations, southern Africa’s politics have been defined by independence-era ruling parties like the ANC, SWAPO, and MPLA. These movements, often backed by Soviet and Chinese arms during anti-colonial struggles, developed a rhetorical skepticism toward the West and ideological solidarity with Eastern powers. However, decades after decolonization, a crucial question arises: do these veteran views still reflect modern realities and the aspirations of the next generation? Evidence increasingly suggests otherwise, as younger populations and emerging political forces prioritize tangible economic opportunities over historical ideological loyalties, challenging traditional narratives. The clearest example of this shift comes from South Africa, the region’s…

California is celebrating 50 years of Genentech, one of the nation’s leading biotechnology companies. The milestone honors decades of scientific innovation that have shaped modern medicine and positioned the United States as a global leader in biotechnology. Founded in 1976, Genentech has played a key role in developing groundbreaking treatments for cancer, immunology, and rare diseases. Its innovations helped launch the biotechnology industry, creating new opportunities for research, manufacturing, and patient care. The company’s success also demonstrates the impact of sustained investment in scientific research and technology. Over the past five decades, Genentech has introduced multiple therapies that have transformed…

UConn has advanced in the NCAA tournament with a thrilling win in the Final Four, as freshmen players led the team to victory over Illinois. The UConn NCAA Final Four win continues their strong postseason run and builds excitement for the championship. The Huskies showcased remarkable teamwork and skill throughout the game, with standout performances from their young players. Freshmen contributed crucial points, rebounds, and defensive plays, giving UConn the edge in a closely contested matchup. Analysts have praised the team’s balance of experience and youthful energy, which has been a key factor in their tournament success. Illinois put up…

Wall Street showed strong gains as analysts highlighted a wave of optimism across U.S. markets. Investors focused on encouraging news, setting aside earlier pessimism, which boosted confidence on the trading floor. The Dow Jones Industrial Average, S&P 500, and Nasdaq all rose steadily, reflecting broad market enthusiasm. Analysts described this as a clear sign that positive news flow is now driving investor behavior. The Dow gained significantly, lifted by strong performances in financial and industrial sectors. The S&P 500 rose by over 1%, showing confidence across multiple industries, while the tech-heavy Nasdaq jumped more than 1.5%, led by major technology…

A new immunotherapy drug has produced striking early results in men with advanced prostate cancer.Researchers reported tumour shrinkage and strong biological responses in some patients. Prostate cancer remains the most common cancer in men in many countries.About 1.5 million men receive a diagnosis worldwide each year. The treatment, called VIR-5500, activates the body’s own immune system.It links killer T-cells directly to cancer cells.This approach helps the immune system destroy tumours that usually evade detection. Scientists designed the drug to switch on mainly inside the tumour.This feature reduces harmful inflammation and limits side effects.It also allows the medicine to stay longer…

Burger King has introduced an AI chatbot to support restaurant staff in the United States.The system connects to employee headsets and operates through a platform called BK Assistant. The voice tool, named Patty, listens to customer interactions at the drive-through.It detects polite words such as “welcome”, “please”, and “thank you”.Managers can use the data to understand service patterns. The company says the system does not score individual workers.It presents the tool as coaching support rather than employee surveillance.Managers receive real-time insights to guide teams and improve hospitality. The platform also updates digital menus when items sell out.It helps staff prepare…

A new oral drug, orforglipron, helped patients lose up to 8% of body weight in one year.The pill also reduced blood sugar more than oral semaglutide. Researchers tested over 1,500 adults with type 2 diabetes across five countries.Participants took daily doses of either treatment for twelve months. Orforglipron activates GLP-1 receptors, slows digestion, and lowers appetite.Patients can take it without fasting, which simplifies daily use. More patients stopped the new drug because of stomach-related side effects.However, experts see strong potential for an easier, cheaper alternative to injections. Regulators still review the medication.Long-term safety and cardiovascular benefits remain uncertain. Specialists expect…

Aston Martin will cut up to 20% of its workforce as it tries to save about £40m. The move could affect around 500 employees. The luxury carmaker had already removed 170 roles at the start of 2025. It said the new reductions are part of a wider restructuring plan. The company wants a leaner organisation for future growth. The announcement came with its latest financial results. Pre-tax losses widened to £363.9m in 2025, up from £289.1m the previous year. Weak demand and higher US tariffs hit trading. Chief executive Adrian Hallmark said the cuts form only one part of the…

Unlicensed gambling companies could lose the right to sponsor Premier League clubs under new government plans. Ministers launched a consultation after a series of controversies and regulatory concerns. Several top-flight teams, including Everton, Fulham and Wolverhampton Wanderers, currently display logos of online casinos or bookmakers without a British licence. Clubs have already agreed to remove all gambling sponsors from the front of shirts after this season. That voluntary move will not cover sleeve deals or other partnerships. The proposed ban would close that gap. It would stop unlicensed operators from using Premier League links to promote their brands, even if…

The UK has paused a clinical trial on puberty blockers after the medicines regulator raised safety concerns. The regulator warned about unknown long-term biological risks and set a minimum age of 14. The Medicines and Healthcare products Regulatory Agency will meet King’s College London next week. They will review the study design and participant safety. The Department of Health and Social Care confirmed the recruitment delay. The Pathways trial will not begin until experts resolve the concerns. The study followed the Cass review, which found weak evidence for the drugs’ benefits in young people. Dr Hilary Cass said a controlled…